Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit — it could ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Pharmacy leaders have issued a fresh warning over the online sale of weight loss jabs, saying there is still a risk to patient safety. The National Pharmacy Association (NPA) has written to ...

New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist semaglutide in preventing cardiovascular diseases may not simply be a result of weight loss ... after this time, but we ...

Share on Pinterest Ozempic (semaglutide ... 20.9% of their body weight over the course of 72 weeks, or about 16.5 months. Calibrate is a 1-year-long comprehensive weight loss program that includes ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...